OMF Canada Triple Giving November logo

 TRIPLE YOUR IMPACT during Triple Giving November | All Donations to OMFCA are TRIPLED through December 2

Donate now for a 3x match
Main Menu
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation® Canada
Donate
Sign Up

From OMF’s CEO, Linda Tannenbaum: A Message of Hope and Action

At OMF Canada (OMFCA), our purpose is clear: to revolutionize the way we understand and treat chronic complex multi-system diseases, with initial focus on ME/CFS and Long COVID, by illuminating their mechanisms, accelerating effective treatments, and empowering personalized care.

Our mission is to drive and fund global collaborative research that unlocks disease biology, delivers precise diagnostics, and advances treatments—giving every patient a pathway to care and hope.

We envision a world where ME/CFS, Long COVID, and related diseases are understood, rapidly diagnosed, and effectively treated—so every patient can live fully.

To see why this work is so urgent, I invite you to watch this short video. It highlights the critical need to accelerate research and shows how OMF is leading global collaborative research to bring answers—and hope—to millions.

Watch the Video
TGN logo: #TRIPLEGIVINGNOVEMBEROMFCA. The phrase is written in bold, uppercase letters with a mix of dark blue and light blue colors. The "OMFCA" text is in light blue, and there is a stylized heart shape in reddish-orange next to it.

Your support directly fuels life-changing research. With our Triple Giving November match in effect until December 2, every gift you give is multiplied—up to $500,000:

$50 becomes $150

$100 becomes $300

$500 becomes $1,500

Triple Your Gift Now

Celebrating the OMF Dream Team

As we advance our mission to drive global collaborative research that unlocks disease biology, delivers precise diagnostics, and develops effective treatments, I want to recognize the extraordinary team that makes this work possible.

They are the engine behind OMF’s impact and I am grateful every day that we are all working together to get people better. 

Please join me in celebrating our incredible Dream Team:

A collage of the foundation team: Linda Tannenbaum, Kimberly Hicks, Jillian Payne, Lynn Bousquet, Lindsay Daguerressar, Danielle Meadows, Karolina Kutilek, Janis Maslyk & Rebecca Morse.

  • Kimberly Hicks, COO/CFO/Treasurer
  • Jillian Payne, Chief Development Officer 
  • Rebecca Morse, Global Operations Director
  • Danielle Meadows, Vice President of Research Programs & Operations
  • Karolina Kutilek, Director of Communication
  • Lindsay Daguerressar, Director of Development
  • Janis Maslyk, Donor Relations and Data Strategy Manager
  • Lynn Bousquet, Website Designer


With gratitude,

Linda's signature




Linda Tannenbaum
Founder & CEO, Open Medicine Foundation

Donate Now

OMFCA also accepts gifts of stock, cryptocurrency, real estate and retirement assets. Learn more today!

Consent management

Consent Preferences

Data Subject Access Request (DSAR) Form 

Microvesicles and viral sequencing
Microvesicles are a type of extracellular vesicle that is released from the cell membrane. Vesicles are small, fluid-filled sacs or vacuoles within the body. Sequencing is a technique used to determine the exact sequence of bases (A, C, G, and T) in a DNA (or viral) molecule.
NMR Metabolomics
NMR (Nuclear Magnetic Resonance) is an instrument/tool used to perform metabolic studies, metabolic profiling, and metabolomics in biofluids and tissues for more than 40 years using magnetic fields. There is a very close connection between metabolic measurements and NMR. This connection has flourished because of NMR’s many unique strengths for characterizing complex mixtures’ chemical composition.
Proteomics
The large-scale study of proteins, which are large, complex molecules that are required for structure, function, and regulation of the human body's tissues and organs.
Autoantibodies
Antibodies that react with self-molecules and that occur in healthy individuals and are referred to as natural antibodies or autoantibodies.
Extracellular DNA for viral reactivation and Mitochondrial DNA
exDNA (extracellular DNA), exDNA is often secreted actively and is used to perform several tasks, thereby offering an attractive target or tool for biotechnological, medical, environmental, and general microbiological applications. Viruses are intracellular parasites that rely to a significant extent on the host cell for replication. Viral reactivation occurs when an active replication of the viral genome results in a lytic (degradation of the cell) infection characterized by the release of new progeny (descendant) virus particles.
Immune cell profiling
The immune system has many important regulatory roles in disease development and progression. Given the emergence of effective immune therapies, reliable predictors of response are needed. Immune cell profiling determines response by evaluating immune cell populations from treated and untreated samples. For our purposes, we will evaluate the white blood cell response to the viral infection using a process called “Cytof.”
Leukocyte Genomics
A leukocyte is a colorless cell circulating in the blood and body fluids and is involved in counteracting foreign substances and disease. A genome is all genetic material of an organism. Genomics is a biology field focusing on the structure, function, evolution, mapping, and editing of genomes. Therefore, leukocyte genomics is the study of all genetic material of leukocytes.
Metabolomics
Metabolomics is a way to study metabolism – that is, through measuring amounts of the metabolites (small molecules) produced by our bodies as we convert food into energy and other molecules that our cells need to survive. Metabolomics technology is ‘large-scale,’ meaning that several thousand metabolites can be measured from a single sample of e.g., blood or urine.
Micro RNA
Cells use Micro RNA to control whether a particular gene is making too much, too little or the normal amount of its protein at a particular time.